边境疟疾:定义问题以应对消除疟疾的挑战
Xiaohong Li1, Robert W Snow2,3, Kim Lindblade4
1Global Malaria Programme, World Health Organization, Geneva, Switzerland. lixia@who.int.
Malaria journal
|August 22, 2023
概括
边境疟疾,定义为跨越共同边界传播,阻碍了全球消除疟疾的努力. 应对复杂的跨境挑战需要超越当前工具的协调战略.
科学领域:
- 全球健康 全球健康
- 传染病流行病学 传染病流行病学
- 公共卫生政策 公共卫生政策
背景情况:
- 边境疟疾,定义为跨越共同的国际陆地边界传播,对消除疟疾的倡议构成重大挑战.
- 消除国家的剩余疟疾传播焦点通常集中在与特有邻国的边境附近.
- 疟疾进口不同于边境疟疾,它涉及持续的传播动态.
相关概念视频
Symbiosis
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


